• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童高危中性粒细胞减少症不明原因发热时经验性抗生素治疗中断的安全性。

Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during high-risk neutropenia in children.

机构信息

CHU Poitiers, Service de Maladies Infectieuses et Tropicales, Poitiers, France; Université de Poitiers, Faculté de médecine et pharmacie, Poitiers, France.

Service de Pédiatrie, CHU Poitiers, Poitiers, France.

出版信息

J Infect. 2024 Jun;88(6):106171. doi: 10.1016/j.jinf.2024.106171. Epub 2024 Apr 30.

DOI:10.1016/j.jinf.2024.106171
PMID:38697268
Abstract

BACKGROUND

ECIL-2021 recommends discontinuing empirical antibiotic therapy (EAT) in febrile-neutropenic children after 72 h of treatment and at least 24-48 h of apyrexia in the case of fever of unknown origin (FUO). These guidelines are rarely applied to high-risk children's neutropenia.

MATERIAL AND METHODS

We retrospectively included all consecutive FUO episodes occurring during profound neutropenia ≥ 10 days in children in our institution. We evaluated the safety of EAT discontinuation in patients for whom the ECIL guidelines were followed compared to those for whom they didn't. We used a combined criterion of mortality and intensive care unit admission at 30 days. We identified risk factors for recurrent fever after EAT discontinuation.

RESULTS

Fifty-one FUO episodes occurred in 37 patients. EAT discontinuation followed ECIL guidelines in 19 (37 %) episodes. No deaths and-or transfers in ICU occurred in the ECIL group. The duration of EAT was shorter by nine days in the group following ECIL guidelines (p < 0.001). We observed 14 (27 %) episodes of recurrent fever. Mucositis was significantly associated with recurrent fever (p < 0.01).

CONCLUSION

EAT discontinuation seems feasible and safe in FUO during prolonged febrile neutropenia in children. However, mucosal lesions should prompt thorough surveillance due to the risk of recurrent fever.

摘要

背景

ECIL-2021 建议在发热性中性粒细胞减少症儿童接受治疗 72 小时后,且在不明原因发热(FUO)的情况下至少发热消退 24-48 小时后停止经验性抗生素治疗(EAT)。这些指南很少适用于高危儿童的中性粒细胞减少症。

材料和方法

我们回顾性地纳入了我院所有连续发生的、中性粒细胞减少症≥10 天且 FUO 持续时间超过 72 小时的患儿。我们评估了在遵循 ECIL 指南和未遵循 ECIL 指南的情况下,EAT 停止的安全性。我们使用死亡率和 30 天内入住 ICU 的综合标准来评估。我们确定了 EAT 停药后复发性发热的危险因素。

结果

37 名患儿中共有 51 次 FUO 发作。19 次(37%)FUO 发作遵循 ECIL 指南停止 EAT。在遵循 ECIL 指南的患儿中,无死亡和/或转 ICU 病例。遵循 ECIL 指南组的 EAT 时间缩短了 9 天(p<0.001)。我们观察到 14 次(27%)复发性发热。口腔黏膜炎与复发性发热显著相关(p<0.01)。

结论

在儿童持续发热性中性粒细胞减少症期间,FUO 中停止 EAT 似乎是可行且安全的。然而,由于存在复发性发热的风险,黏膜损伤应引起彻底监测。

相似文献

1
Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during high-risk neutropenia in children.儿童高危中性粒细胞减少症不明原因发热时经验性抗生素治疗中断的安全性。
J Infect. 2024 Jun;88(6):106171. doi: 10.1016/j.jinf.2024.106171. Epub 2024 Apr 30.
2
Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.发热性中性粒细胞减少症中经验性抗菌治疗的早期停药:ANTIBIOSTOP 研究。
Infect Dis (Lond). 2018 Jul;50(7):539-549. doi: 10.1080/23744235.2018.1438649. Epub 2018 Feb 16.
3
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.高危血液恶性肿瘤中性粒细胞减少症患者早期停用抗生素后发热复发的安全性和风险:一项多中心观察性研究。
J Antimicrob Chemother. 2022 Aug 25;77(9):2546-2556. doi: 10.1093/jac/dkac190.
4
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.对部分发热性中性粒细胞减少的癌症患儿进行短期静脉经验性抗生素治疗。
Infection. 2002 Jan;30(1):17-21. doi: 10.1007/s15010-002-2094-1.
5
Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition.患有恶性肿瘤或血液系统疾病的儿科患者在经验性抗生素治疗发热和中性粒细胞减少症停药后反复发热的危险因素。
J Pediatr. 1994 May;124(5 Pt 1):703-8. doi: 10.1016/s0022-3476(05)81358-7.
6
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.中性粒细胞减少的急性髓系白血病和高危骨髓增生异常综合征患者经验性抗生素治疗的早期停药。
Antimicrob Resist Infect Control. 2020 May 27;9(1):74. doi: 10.1186/s13756-020-00729-2.
7
Discontinuation of empirical antibiotic therapy in neutropenic acute myeloid leukaemia patients with fever of unknown origin: is it ethical?中性粒细胞减少的急性髓系白血病发热原因不明患者停用经验性抗生素治疗:这合乎伦理吗?
Clin Microbiol Infect. 2014 Jul;20(7):O453-5. doi: 10.1111/1469-0691.12445. Epub 2013 Dec 9.
8
[Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].[哌拉西林-他唑巴坦与奈替米星联合治疗儿童发热性中性粒细胞减少症发作]
Med Mal Infect. 2005 Jun;35(6):357-62. doi: 10.1016/j.medmal.2005.04.004.
9
Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia.儿童、青少年和青年发热性中性粒细胞减少症患者骨髓抑制期间抗生素停药的分析。
J Microbiol Immunol Infect. 2021 Dec;54(6):1056-1060. doi: 10.1016/j.jmii.2020.07.014. Epub 2020 Aug 6.
10
Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.儿童发热性中性粒细胞减少综合征:原发性、持续性和复发性发热的危险因素及预后
J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e962-e971. doi: 10.1097/MPH.0000000000002221.